Welcome to our dedicated page for BioSig Technologies SEC filings (Ticker: BSGM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BSGM SEC filings archive on Stock Titan presents the regulatory record of the company formerly known as BioSig Technologies, Inc., which has since rebranded as Streamex Corp. and now trades under the symbol STEX. These documents trace the company’s transition from a medical device technology issuer to a business focused on real-world asset and gold tokenization.
Key filings include multiple Current Reports on Form 8-K detailing material events such as the merger with Streamex Exchange Corporation, the amendment to the certificate of incorporation changing the corporate name to Streamex Corp., and the Nasdaq ticker symbol change from BSGM to STEX. Other 8-K filings describe the secured convertible debenture purchase agreement with an institutional investor, the issuance of an initial tranche of convertible debentures, and related security and registration rights agreements.
The archive also contains a definitive proxy statement on Form DEF 14A for the company’s annual meeting, which outlines proposals including director elections, executive compensation advisory votes, auditor ratification, and amendments to the long-term incentive plan. Additional filings report amendments to the certificate of incorporation to increase authorized shares and to classify the board into staggered terms, as well as a tokenized yield partnership agreement related to precious-metal lease and bond programs.
On Stock Titan’s filings page, investors can review these historical BSGM documents alongside AI-powered summaries that explain the main terms, structures, and implications of each report. The feed updates as new Streamex Corp. (STEX) filings appear in the SEC’s EDGAR system, allowing users to follow the company’s ongoing regulatory disclosures, including future 10-K annual reports, 10-Q quarterly reports, and any Form 4 insider transaction filings associated with the successor entity.
Streamex Corp.’s Chief Investment Officer, Williams Mitchell Young, reported buying additional common stock. On January 23, 2026, he purchased 51,511 shares of Streamex Corp. common stock in the open market at a weighted average price of $3.0256 per share, with individual trade prices ranging from $3.00 to $3.08. Following this transaction, he directly owns 1,051,511 shares of Streamex Corp. common stock.
Streamex Corp. director Lekstrom Morgan Lee reported an indirect transaction involving 41,000 shares of Common Stock on January 23, 2026, at a weighted average price of $3.1338 per share. The Form 4 shows the transaction with code “P” and indicates that 48,000 shares of Common Stock were beneficially owned after the transaction. The shares are held indirectly through All Mine Consulting Ltd, an entity for which the reporting person holds voting and dispositive control. A footnote explains that the reported price is a weighted average of multiple trades executed at prices ranging from $3.06 to $3.16902 per share.
Streamex Corp is issuing 11,666,667 shares of common stock at $3.00 per share in a primary offering, with underwriters holding a 30-day option for up to 1,750,000 additional shares. Gross proceeds are $35.0 million, with estimated net proceeds of about $32.28 million after fees.
The company plans to use the cash mainly to repay portions of its $50 million secured convertible debentures with Yorkville, which bear 4.00% interest and mature in 2027, and for working capital and general corporate purposes. Shares outstanding are expected to increase from 69,769,461 to 81,436,128, or 83,186,128 if the underwriters’ option is fully exercised, meaning meaningful dilution for new investors buying at a price well above book value.
The filing highlights substantial accumulated losses, going concern warnings, a highly leveraged balance sheet, and significant risks tied to Streamex’s gold-linked tokenization strategy, regulatory uncertainty around digital assets, and reliance on continued access to capital markets.
Streamex Corp is conducting a primary offering of common stock under its shelf registration. The shares will be sold through underwriters, with an additional 30‑day option for more shares, and the company plans to use net proceeds mainly to repay secured convertible debentures and for working capital and general corporate purposes.
The filing highlights Streamex’s shift into gold‑backed tokenization alongside its legacy PURE EP™ medical device platform, while noting substantial historical losses, an accumulated deficit of about $294.1 million as of September 30, 2025, and prior going‑concern warnings. As of January 16, 2026, Streamex reports unaudited cash of $21.5 million, $26.3 million of gold holdings, $10.5 million of marketable securities, and $50.0 million of senior secured convertible debt. The company also discloses an open SEC comment questioning its accounting for the Streamex acquisition and presents illustrative pro forma adjustments showing total assets of approximately $15.5 million and liabilities of approximately $9.9 million if the deal were treated as a reverse recapitalization.
Streamex Corp. filed an amended current report to correct how it previously described the outcome of Proposal 6 at its September 5, 2025 special stockholder meeting. The proposal sought to amend the company’s Certificate of Incorporation to create a classified board of directors with three classes serving staggered three-year terms. The company now states that, although 15,424,979 votes were cast "for", 1,009,783 "against", with 203,852 abstentions and 3,483,433 broker non-votes, the proposal did not receive the required affirmative vote of a majority of the outstanding voting power under Section 242 of the Delaware General Corporation Law. The company nonetheless had filed a charter amendment reflecting adoption of the classified board structure on November 19, 2025 and held its December 30, 2025 annual meeting in accordance with that structure.
Streamex Corp. director Kevin Roy Gopaul reported an equity grant in a Form 4 filing. On January 5, 2026, he was awarded 100,000 shares of Streamex common stock as a restricted stock award, coded as an acquisition. The filing shows a transaction price of $0 per share, reflecting that this was a grant rather than a market purchase.
According to the footnote, the award was granted under Streamex’s 2023 Equity Incentive Plan and was based on a closing market price of $3.18 per share on the grant date. Following this transaction, Gopaul beneficially owns 100,000 shares of common stock in a direct capacity.
Streamex Corp. entered into a Share Purchase Agreement with Terra Capital Natural Resources Fund Pty Ltd on December 11, 2025 to acquire a 9.9% equity interest in Empress Royalty Corp. Streamex is acquiring 12,671,297 shares of Empress common stock in exchange for issuing 2,443,750 shares of its own common stock at an implied price of US$5.00 per STEX share.
The exchange values the transaction at C$17,106,251.62, or US$12,218,751.00 in aggregate. Streamex explains that the deal gives it direct exposure to Empress’ portfolio of gold and silver royalty and streaming assets, supporting its strategy of expanding into real-world, yield-generating commodity assets alongside regulated digital asset infrastructure. The share issuance was an unregistered sale of equity securities with no underwriters or placement agents involved.
Streamex Corp. filed a Form 4 reporting an equity grant to its Chief Financial Officer. On 11/18/2025, the CFO received 60,000 shares of Streamex common stock as an acquired (A) transaction at a stated price of $0 per share under the company’s 2023 Equity Incentive Plan, described as a restricted stock award.
The award was granted based on a closing market price of $4.14 per share on the grant date and is scheduled to vest in full on the one-year anniversary of that date. Following this grant, the reporting person beneficially owned a total of 295,000 shares of Streamex common stock, held directly. No derivative securities transactions were reported.
Streamex Corp. (STEX) director Morgan Lekstrom reported an indirect open-market purchase of the company’s common stock. On 11/21/2025, a total of 7,000 shares of common stock were acquired at a price of $3.58 per share, coded as a purchase transaction. After this trade, the reporting person is shown as beneficially owning 7,000 shares.
The filing states that these shares are held indirectly through All Mine Consulting Ltd., an entity over which the reporting person has voting and dispositive control. The Form 4 is filed as a single-reporting-person filing and reflects only non-derivative equity securities, with no derivative positions reported in Table II.
Streamex Corp. (STEX) reported that a director received a grant of 125,000 shares of common stock as a restricted stock award on November 18, 2025 under the company’s 2023 Equity Incentive Plan. The award was valued using a closing share price of $4.14 on the grant date and will vest in full on the one-year anniversary of that date. Following this grant, the director beneficially owns 228,345 shares of Streamex common stock, held directly.